Spandana Thenkabail

  • Citations Per Year
Learn More
Vagus nerve stimulation (VNS) is currently Food and Drug Administration-approved for treatment of both medically refractory partial-onset seizures and severe, recurrent refractory depression, which has failed to respond to medical interventions. Because of its ability to regulate mechanisms well-studied in neuroscience, such as norepinephrine and serotonin(More)
  • Fawzi Abukhalil, Aakash N. Bodhit, +8 authors Vishnumurthy Shushrutha Hedna
  • Journal of atrial fibrillation
  • 2013
Atrial fibrillation (AF) has a huge impact on clinical stroke because it is the primary cause of cardio-embolism, which constitutes ~20% of all strokes. As a result, there is a great need to explore safer and more effective primary and secondary prophylactic agents. In this article, we discuss the overlapping issues pertaining to AF from both a neurology(More)
  • 1